Cargando…

Rocuronium-induced respiratory paralysis refractory to sugammadex in Charcot-Marie-Tooth disease

PURPOSE: Prolonged postoperative neuromuscular respiratory paralysis after administration of a nondepolarizing neuromuscular blocking agent is a serious concern during anesthetic management of patients with Charcot-Marie-Tooth disease (CMTD). Some recent reports have described rocuronium use without...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hiramatsu, Sakiko, Moriwaki, Katsuyuki, Nakao, Miwako, Tsutsumi, Yasuo M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Reports / Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850256/ https://www.ncbi.nlm.nih.gov/pubmed/34902106 http://dx.doi.org/10.1007/s12630-021-02168-y

Ejemplares similares

Rocuronium-sugammadex use for electroconvulsive therapy in a hemodialysis patient: a case report
por: Kurita, Shigeaki, et al.
Publicado: (2016)

Noncompaction Cardiomyopathy with Charcot-Marie-Tooth Disease
por: Eltawansy, Sherif Ali, et al.
Publicado: (2015)

Audiological findings in the Charcot-Marie-Tooth Disease
por: Fukushima, Erika, et al.
Publicado: (2015)

Effects of rocuronium, sugammadex and rocuronium-sugammadex complex on coagulation in rats
por: Lima Cavalcanti, Ismar, et al.
Publicado: (2020)

Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report-
por: Choi, Shu Chung, et al.
Publicado: (2020)

Concurrent positive skin tests to prophylactic antibiotics and rocuronium in two patients with life-threatening anaphylaxis after induction of anesthesia
por: Yasuda, Masako, et al.
Publicado: (2021)

GJB1 Gene Analysis in Two Extended Families with X-Linked Charcot-Marie-Tooth Disease
por: Kovale, Sabine, et al.
Publicado: (2021)

Residual paralysis caused by 50 mg rocuronium after reversal with 4 mg/kg sugammadex: a case report
por: Uzawa, Kohji, et al.
Publicado: (2021)

Case series: Childhood Charcot-Marie-Tooth: Predominance of axonal subtype
por: Thongsing, Apirada, et al.
Publicado: (2019)

Diagnosis of Charcot-Marie-Tooth Disease
por: Banchs, Isabel, et al.
Publicado: (2009)

Sugammadex and rocuronium-induced anaphylaxis
por: Takazawa, Tomonori, et al.
Publicado: (2015)

Multiple respiratory complications in a patient with Charcot-Marie-Tooth disease with MFN2 mutation
por: Sano, Tomoya, et al.
Publicado: (2022)

Cochlear Implantation in Charcot-Marie-Tooth Disease: Case Report and Review of the Literature
por: Anzalone, C. Lane, et al.
Publicado: (2018)

Hidden Charcot-Marie-Tooth 1A as Revealed by Peripheral Nerve Imaging
por: Shibuya, Kazumoto, et al.
Publicado: (2019)

MFN2-related Charcot-Marie-Tooth Disease with Atypical Ocular Manifestations
por: Nan, Haitian, et al.
Publicado: (2021)

Charcot–Marie–Tooth disease and intracellular traffic
por: Bucci, Cecilia, et al.
Publicado: (2012)

Anejaculation in a patient with Charcot–Marie–Tooth
por: Cannarella, Rossella, et al.
Publicado: (2018)

Charcot-Marie-Tooth: From Molecules to Therapy
por: Morena, Jonathan, et al.
Publicado: (2019)

MBCL-27. ASSOCIATION OF MEDULLOBLASTOMA WITH CHARCOT-MARIE-TOOTH DISEASE
por: Watanabe, Kenichiro, et al.
Publicado: (2020)

Anaphylactic shock after sugammadex administration, induced by formation of a sugammadex-rocuronium complex -a case report-
por: Kim, Gunn Hee, et al.
Publicado: (2019)

Successful management of rocuronium-induced anaphylaxis with sugammadex: A case report
por: Hung, Sheng-Kai, et al.
Publicado: (2022)

Charcot-Marie-Tooth 1A Concurrent with Schwannomas of the Spinal Cord and Median Nerve
por: Kwon, Joo Young, et al.
Publicado: (2009)

The Role of Rehabilitation in the Management of Patients with Charcot-Marie-Tooth Disease: Report of Two Cases
por: Dimitrova, Erieta Nikolikj, et al.
Publicado: (2016)

A novel mutation in the FGD4 gene causing Charcot‐Marie‐Tooth disease
por: Zis, Panagiotis, et al.
Publicado: (2017)

Sleep and Memory Disorders in a Patient Suffering from Charcot-Marie-Tooth Disease
por: FLORESCU, C., et al.
Publicado: (2017)

Membranous Nephropathy in a Patient with Charcot-Marie-Tooth Disease: Association of Myelin Mutations
por: Anandh, U., et al.
Publicado: (2018)

Anesthesia in a patient with Charcot-Marie-Tooth disease with pneumothorax: a case report
por: Kim, Jae Won, et al.
Publicado: (2019)

Repeat dosing of rocuronium-sugammadex: unpredictable
por: Kim, Yoon-Hee
Publicado: (2014)

Charcot-Marie-Tooth Disease: Seventeen Causative Genes
por: Lee, Jung-Hwa, et al.
Publicado: (2006)

Balance and muscle power of children with Charcot-Marie-Tooth
por: Silva, Tais R., et al.
Publicado: (2014)

Preimplantation genetic diagnosis for Charcot-Marie-Tooth disease
por: Lee, Hyoung-Song, et al.
Publicado: (2013)

A SIMPLE explanation for Charcot-Marie-Tooth disease
por: Short, Ben
Publicado: (2012)

ACQUIRED PES CAVUS IN CHARCOT-MARIE-TOOTH DISEASE
por: Maranho, Daniel Augusto, et al.
Publicado: (2015)

Charcot Marie Tooth Disease. A Single Disorder?
por: Fontés, Michel
Publicado: (2018)

Impaired Mitochondrial Mobility in Charcot-Marie-Tooth Disease
por: Schiavon, Cara R., et al.
Publicado: (2021)

Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies
por: Stavrou, Marina, et al.
Publicado: (2021)

Anaesthetic implications in patient with Charcot-Marie-Tooth disease
por: Kapoor, Hemlata, et al.
Publicado: (2021)

The Current State of Charcot–Marie–Tooth Disease Treatment
por: Okamoto, Yuji, et al.
Publicado: (2023)

Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient
por: Koros, Christos, et al.
Publicado: (2013)

Misunderstanding of Foot Drop in a Patient with Charcot-Marie-Tooth Disease and Lumbar Disk Herniation
por: Han, Youngmin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5e8jtp2f2tvm8fu2qu26jgs2vn